Skip to main content
SpringerLink
Log in

Statistics and ethics in medical research

  • Published:
Science and Engineering Ethics Aims and scope Submit manuscript

Abstract

Ethical conduct is an essential component in research, especially in medical research. Statistical methods for design and analysis are powerful research tools if used properly. Abuse of these principles and methods are just as unethical as other laboratory or clinical misconduct. Inadequate research design can produce worthless results and thus wastes effort and valuable resources. For clinical research, patient resources are wasted. Inappropriate analysis of data can also produce misleading results and conclusions. For clinical research, inferior therapy might be given to patients as a consequence. These ethical concerns can have implications for and affect the individuals responsible for the statistical design and analysis. Examples are provided which illustrate some possible abuses and inappropriate pressures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Macrina, F.L. (1995) Scientific integrity: An introductory text with cases. ASM Press, Washington DC.

    Google Scholar 

  2. Appendix II (The World Medical Association Declaration of Helsinki). In: Beauchamp, T.L. & Childress, J.F. (1979) Principles of biomedical ethics, Oxford University Press, New York,: 289–93.

  3. CIOMS/World Health Organization [WHO] (1993) International Ethical Guidelines for Biomedical Research Involving Human Subjects, Geneva:CIOMS.

    Google Scholar 

  4. Levine, R.J. (1993) New international ethical guidelines for research involving human subjects. Annals of Internal Medicine 119: 339–341.

    Google Scholar 

  5. National Commission for Protection of Human Subjects of Biomedical and Behavioral Research (1978) The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research (DHEW Publication No. (OS) 78-0012), Government Printing Office, Washington D.C.

    Google Scholar 

  6. OPRR Reports (1994) Code of Federal Regulations: (45 CFT 46) Protection of Human Subjects. National Institutes of Health, Department of Health and Human Services, Revised June 18, 1991. Reprinted March.

  7. National Institutes of Health (1990) Guidelines for the conduct of research at the National Institutes of Health. Bethesda, MD.

    Google Scholar 

  8. Broad, W. & Wade, N. (1982) Betrayers of the truth: Fraud and deceit in the halls of science. Simon and Schuster, New York.

    Google Scholar 

  9. Lock, S. & Well, F. (eds) (1993) Fraud and misconduct in medical research. Brit Med J Publishing Group, London.

    Google Scholar 

  10. Friedman, L., Furberg, C., & DeMets, D. (1996) Fundamentals of Clinical Trials. John Wright - PSG Inc., Littleton, MA, 1981; 2nd edition 1985; Mosby-Year Book, Inc., St. Louis, MO. 3rd edition.

    Google Scholar 

  11. Taubes, G. (1995) Epidemiology faces its limits. Science 269: 164–169.

    Article  Google Scholar 

  12. Peto, R., Doll, R., Buckley, J.D. & Sporn, M.B. (1981) Can dietary beta-carotene materially reduce human cancer rates? Nature 290: 201–208.

    Article  Google Scholar 

  13. The Alpha-Tocopherol, Beta Carotene Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine 330(15):1029–1035.

    Article  Google Scholar 

  14. Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., Glass, A., Keogh, J.P., Meyskens, F.L., Valanis, B., Williams, J.H., Barnhart, S., Hammer, S. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine 334: 1150–1155.

    Article  Google Scholar 

  15. Hennekens, C.H., Buring, J.E., Manson, J.E., Stampfer, M., Rosner, B., Cook, N.R., Belanger, C., LaMotte, F., Gaziano, J.M., Ridker, P.M., Willett, W. and Peto, R. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New England Journal of Medicine 334(18): 1145–1149.

    Article  Google Scholar 

  16. Freiman, J.A., Chalmers, T.C., Smith, H. Jr., Kuebler, R.R. (1978) The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial: survey of 71 “negative” trials. New England Journal of Medicine 299(13): 690–694.

    Article  Google Scholar 

  17. Fleming, T.R. and DeMets, D.L. (1996) Surrogate end points in clinical trials: Are we being mislead? Annals of Internal Medicine 125(7): 605–613.

    Google Scholar 

  18. Temple, R.J. (1995) A regulatory authority’s opinion about surrogate endpoints. In: Nimmo, W.S. & Tucker, G.T.: eds. Clinical Measurement in Drug Evaluation, J Wiley, New York.

    Google Scholar 

  19. Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine 312(6): 406–412.

    Google Scholar 

  20. Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effects of the antiarrhythmic agent moricizine on survival after myocardial infarction. New England Journal of Medicine 327: 227–233.

    Article  Google Scholar 

  21. Friedman, L.M., Bristow, J.D., Hallstrom, A., Schron, E., Proschan, M., Verter, J., DeMets, D.L., Fisch, C., Nies, A.S., Ruskin, J., Strauss, H., Walters, L. (1993) Data monitoring in the Cardiac Arrhythmia Suppression Trial. Online Journal of Current Clinical Trials Doc 79, ISSN 1059-2725, July 31, 1993.

  22. Packer, M., Carver, J.R., Rodehoffer, R.J., Ivanhoe, R.J., DiBianco, R., Zeldis, S.M., Hendrix, G.H., Bomme, W.J., Elkayam, U., Kukin, M.L., Mallis, G.I., Sollano, J.A., Shannon, J., Tandon, P.K., and DeMets, D.L. for the PROMISE Study Research Group (1991) Effect of oral milrinone on mortality in severe chronic heart failure. New England Journal of Medicine 325: 1468–1475.

    Article  Google Scholar 

  23. Packer, M., Rouleau, J., Swedberg, K, et al. and the PROFILE Investigators (1993): Effect of Flosequinan on survival in chronic heart failure: Preliminary results of the PROFILE study. Circulation S1411, October.

  24. Sande, M.A., Carpenter, C.C., Cobbs, D.G., Holmes, K.K., Sanford, J.D. and members of the State-of-the-Art panel on anti-retroviral for adult HIV infected patients (1993) State-of-the-Art Conference (June 23–25, 1993) on anti-retroviral therapy for adult HIV infected patients: Final report. Journal of the American Medical Association 270(12): 2583–89.

    Article  Google Scholar 

  25. Schechter, P.J., Friedewald, W.T., Bronzert, D.A. et al (1972) Idiopathic hypogeusia: a description of the syndrome and a single blind study with zinc sulfate. In: Pfeiffer C (ed): International Review of Neurobiology, Supplement 1. Academic Press, pp 125–140.

  26. Henkin, R.I., Schecter, P.J., Friedewald, W.T., DeMets, D.L., Raff, M (1976) A double-blind study of the effects of zinc sulfate on taste and smell dysfunction. American Journal of Medical Science 272: 285–299.

    Google Scholar 

  27. Karlowski, T.R., Chalmers, T.C., Frenkel, L.D., Kapikian, A.Z., Lewis, T.L., Lynch, J.M. (1975) Ascorbic acid for the common cold: a prophylactic and therapeutic trial. Journal of the American Medical Association 231(10): 1038–1042.

    Article  Google Scholar 

  28. Sigma Xi, The Scientific Research Society (1991) Honor in Science, Sigma Xi, The Scientific Research Society, Research Triangle Park, NC.

    Google Scholar 

  29. May, G.S., DeMets, D.L., Friedmanm L.M., Furberg, C., Passamani, E. (1981) The randomized clinical trial: Bias in analysis. Circulation 64: 669–673.

    Google Scholar 

  30. Redmond, C., Fisher, B., Wieand, H.S. (1983) The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival. Cancer Treatment Reports 67: 519–526.

    Google Scholar 

  31. Anturane Reinfarction Trial Research (1980) Sulfinpyrazone in the prevention of sudden death after myocardial infarction. New England Journal of Medicine 302: 250–256.

    Article  Google Scholar 

  32. Anturane Reinfarction Trial Policy Committee (1982) The Anturane Reinfarction Trial: Reevaluation of outcome. New England Journal of Medicine 306: 1005–1008.

    Article  Google Scholar 

  33. Temple, R. and Pledger, G.W. (1980) The FDA’s critique of the Anturane Reinfarction Trial. New England Journal of Medicine 303: 1488–1492.

    Article  Google Scholar 

  34. Bailey, K.R. (1991) Detecting fabrication of data in a multicenter collaborative animal study. Controlled Clinical Trials 12: 741–752.

    Article  Google Scholar 

  35. Knox, R. (1983) The Harvard fraud case: Where does the problem lie? Journal of the American Medical Assocociation 249:1797–1807.

    Article  Google Scholar 

  36. Fisher, B., Anderson, S., Redmond, C.K., Wolmark N., Wickerhamm D.L., Cronin, W.M. (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. New England Journal of Medicine 333: 1456–1461.

    Article  Google Scholar 

  37. Christian, M.C., McCabe, M.S., Korn, E.L., Abrams, J.S., Kaplan, R.S., Friedman, M.A. (1995) The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project protocol B-06. New England Journal of Medicine 333: 1469–1474.

    Article  Google Scholar 

  38. Peto, R., Collins, R., Sackette, D., Darbyshire, J., Babiker, A., Buyse, M., Stewart, H., Baum, M., Goldhirsch, A., Bonadonna, G., Valagussa, P., Rutqvist, L., Elbourne, D., Davies, C., Dalesio, O., Parmar, M., Hill, C., Clarke, M., Gray, R., Doll, R. (1997) The trials of Dr. Bernard Fisher: A European perspective on an American episode. Controlled Clinical Trials 18:1–13.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, 600 Highland Avenue, K6/446, 53792-4675, Madison, WI, USA

    David L. DeMets Ph.D.

Authors
  1. David L. DeMets Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeMets, D.L. Statistics and ethics in medical research. SCI ENG ETHICS 5, 97–117 (1999). https://doi.org/10.1007/s11948-999-0059-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11948-999-0059-9

Keywords

Search

Navigation